Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "OPEN"

712 News Found

Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research
Public Health | June 16, 2022

Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research

The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.


Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant
Healthcare | June 16, 2022

Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant

63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)


Lupin Diagnostics launches its first regional reference lab in Patna
Diagnostic Center | June 16, 2022

Lupin Diagnostics launches its first regional reference lab in Patna

Expanding diagnostics footprint in East India


Merck KGaA collaborates with University of Bonn to advance molecular machine learning
Digitisation | June 15, 2022

Merck KGaA collaborates with University of Bonn to advance molecular machine learning

The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning


India's bio-economy has grown 8 times in the last 8 years: PM Modi
Biotech | June 10, 2022

India's bio-economy has grown 8 times in the last 8 years: PM Modi

We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”


Bayer’s Vividion emerging as significant player in San Diego Biotech hub
Biotech | June 10, 2022

Bayer’s Vividion emerging as significant player in San Diego Biotech hub

Bayer now present in four of the largest biotechnology hubs in the United States


Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis
Drug Approval | June 09, 2022

Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis

TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.


CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox
Diagnostic Center | June 08, 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit


NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai
Policy | June 08, 2022

NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai

The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients